[PDF] Top 20 Moderated Poster Session 5: Oncology: Bladder
Has 10000 "Moderated Poster Session 5: Oncology: Bladder" found on our website. Below are the top 20 most common "Moderated Poster Session 5: Oncology: Bladder".
Moderated Poster Session 5: Oncology: Bladder
... The 5-year overall survival (OS) was 56%, 39% and 65% (log-rank p < ...The 5-year disease-specific survival (DSS) was 66%, 52%, 74% (log-rank p = ...the 5-year recurrence-free survival (RFS) was ... See full document
5
Moderated Poster Session V: Oncology/Laparoscopy/Robotics/Basic Science
... Intravesical bladder irrigations were performed for three ...of bladder cancer related ...human bladder cancer cell line 253J and GAPDH ...assessed. Bladder cancer gene panels used in the ... See full document
6
Moderated Poster Session 1: Oncology 1
... confined bladder cancer (cT2 or less) who underwent radical ...prospective bladder infor- mation system database and incorporated into our marker-based algo- ... See full document
10
Moderated Poster Session I: Oncology 1
... Background: The treatment of musle invasive bladder tumours remains challenging for urologic oncologists. Targeted radiation therapy coupled with chemotherapy has become as a promising treatment modality com- ... See full document
6
Moderated Poster Session 5: Renal Transplant, Laparoscopy & Female Urology
... Results: There was 330 patients responded back to the questionnairs. The average age was 54.8 years (± 12.9) and the median follow-up was 143.9 (± 76.9) months?. A total of 128 (38.8%) patients underwent the TVT ... See full document
5
Moderated Poster Session 3: Oncology II
... Deleterious bladder effects after radical prostatectomy such as reduced compliance, decreased capacity, and hyperactivity influence recovery of urinary ...either 5 mg SS daily or ... See full document
7
Moderated Poster Session V: Oncology 2
... Overall, the 23 discrepant pathology reports that lead to significant change in management could be summarized as follows: T category change after review lead to 13 radical cystectomies being proposed and an additional 2 ... See full document
6
Moderated Poster Session V: Oncology 2
... Methods: After obtaining IRB approval, we retrospectively searched our institution’s clinical CPT coding for thiotepa use. Over the previous 10 years, there were 18 patients with thiotepa use recorded in their chart. ... See full document
6
Moderated Poster Session III: Oncology 1
... Results: We identified 190 TURBT cases of large tumors using either monopolar or bipolar electrocautery. Cautery artifact was mentioned in 15/190 (7.9%) pathological reports. After re-review by a genitourinary ... See full document
7
Moderated Poster Session 6: Oncology
... Introduction and Objective: The efficacy of segmental ureterectomy (SU) relative to nephroureterectomy with bladder cuff removal (NUC) or without bladder cuff removal (NU) was examined in patients with ... See full document
6
Moderated Poster Session I: Oncology
... Results: Demographic information was similar among the groups. Diagnostic workup (including endoscopic findings) was similar, although Group A had more patients with a history of cystectomy for bladder can- cer ... See full document
6
Moderated Poster Session 5: Laparoscopy/Robotics & Stones/Endourology
... Results: 2 patients were performed using this technique. In one case, the patient (61 y.o. male, BMI of 31) had a double right ureteral stricture above the iliac vessels that had been dilated and stented multiple times. ... See full document
7
Moderated Poster Session 2: Basic Science
... Methods: We included 290 patients from three university hospitals (Dallas, N=132; Toronto, N=104; Turku, N=54) who underwent radical cystectomy with at least a bilateral pelvic lymph-adenectomy. Patients who received ... See full document
8
Moderated Poster Session 8: Miscellaneous
... Materials and Methods: Human MSCs were cultured from bone marrow aspirates. To induce myogenic differentiation in vitro, human MSCs were exposed to 5-azacytidine (AZA) in passage (P) 1. Native MSCs in P1 and P3 as ... See full document
5
Moderated Poster Session II: Reconstruction/Andrology
... Background: Stuttering priapism is a recurrent form of ischemic priapism whereby unwanted painful erections occur repeatedly with intervening periods of detumescence. While each recurrent episode should be treated ... See full document
7
Moderated Poster Session 1: Basic Science
... Methods: Utilizing the subrenal prostatic recapitulation model for tis- sue recombination, rat urogenital mesenchyme (rUGM) was microdis- sected from rat embryos and combined with 10-20 mg slivers of prostate tumor or ... See full document
7
Moderated Poster Session 2: Functional Urology
... Results: In the Medicare population there were 358 patients who received percutaneous tests and 1132 a 2-stage (permanent) lead placement; 91.3% of patients were white and 73.6% were female. Of all percutaneous tests, ... See full document
5
Moderated Poster Session 2: Kidney Cancer
... to 5 small incisions for port ...to 5 cm skin incision (based on the size of the specimen) was made along the skin crease of the ...two 5-mm small-profile conventional ports were placed through sepa- ... See full document
6
Moderated Poster Session 2: Basic Research
... Antiproliferative effects of combined therapy (Gefitinib and C-DIM) com- pared to each drug alone were also monitored in vitro, by MTT assays and in vivo, on nude mice inoculated with the more resistant cell lines (KU-7 ... See full document
7
Moderated Poster Session 8: Kidney Cancer
... Introduction and Objective: Sunitinib is an established treatment for metasta- tic renal cell carcinoma (RCC). Neoadjuvant sunitinib may facilitate surgi- cal resection by reducing primary tumor size and may decrease ... See full document
5
Related subjects